Skip to content Skip to footer
How To Sleep With Sleep Apnea

How To Sleep With Sleep Apnea?

Struggling to get a good night's sleep because of sleep apnea? You're not alone. Many people face this challenge every night. But don't worry! Learning how to sleep with sleep apnea can transform those restless hours into peaceful slumber. Imagine closing your eyes and drifting off easily, breathing comfortably through the night. This dream can become…

Read More

Do nasal strips help with sleep apnea

Do Nasal Strips Help With Sleep Apnea?

Tossing and turning all night, unable to get restful sleep. Loud snoring or gasping disturbs your bed partner. Feeling exhausted during the day no matter how many hours you spend in bed. These are common issues for the nearly 22 million Americans suffering from sleep apnea. While oral medical devices are the go-to treatment, some people wonder…

Read More

Vivos Stock

Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds

February 15, 2024 08:00 ET| Source: Vivos Therapeutics, Inc LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea…

Read More

CPAP Recall Alert - Vivos Therapeutics

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

United Healthcare Updated Medical Policy Favoring Oral Appliance Therapies and Recent Recalls of Many ResMed and Philips Respironics' CPAP Devices Create Significant Revenue Opportunities for Vivos Devices February 06, 2024 07:30 ET| Source: Vivos Therapeutics, Inc LITTLETON, Colo., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and…

Read More

Vivos mmRNA appliance

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

New Dentist Inquiries Jumped 600% and Signed Dentist Enrollment Contracts up 38% Sequentially Over Q3 CARE Oral Medical Device Unit Orders Increased 26% Following FDA Clearance LITTLETON, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly…

Read More